BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
-15.69%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$508M
AUM Growth
+$508M
(-14%)
Cap. Flow
+$40.8M
Cap. Flow
% of AUM
8.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
3
Reduced
–
Closed
–
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$27.3M |
| 2 |
Lineage Cell Therapeutics
LCTX
|
$7.29M |
| 3 |
STAAR Surgical
STAA
|
$3.88M |
| 4 |
CYNO
Cynosure, Inc. Class A
CYNO
|
$2.36M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 46.78% |
| 2 | Consumer Staples | 42.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $216M | 42.55% | 1,599,136 | – | – |
|
|
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $104M | 20.39% | 1,619,968 | – | – |
|
|
3
STAAR Surgical
STAA
$1.36B
| $66.9M | 13.17% | 8,617,562 +499,980 | +6% | +$3.88M |
|
|
4
Lineage Cell Therapeutics
LCTX
$267M
| $60.8M | 11.97% | 20,264,396 +2,431,611 | +14% | +$7.29M |
|
|
5
iShares Russell 2000 ETF
IWM
$67B
| $27.3M | 5.38% | +250,000 | New | +$27.3M |
|
|
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
| $26.9M | 5.3% | 895,455 +78,426 | +10% | +$2.36M |
|
|
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $6.35M | 1.25% | 1,641,025 | – | – |
|